Methods for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies
US9617600B2 · kind B2 · utility
0Cited by
27References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 17, 2010 |
| Grant date | Apr 11, 2017 |
| Priority date | — |
| Expiry date | Oct 7, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods and kits useful for predicting or assessing responsiveness of a patient having B-cell lymphoma to treatment with anti-CD40 antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.